Samplfy

Company Overview

Snapshot

Founded in July 2020 by Varda Aberbach, Samplfy operates with 1–10 employees. The company holds a patent for its innovative urine collection system, addressing a critical need in women's health diagnostics.

Business overview

Samplfy develops a medical device and digital health solution focused on improving urine collection for women, aiming to enhance the reliability of diagnostic test results. The company's core technology includes patented, single-use, environment-friendly urine collectors that enable hands-free collection and secure sample transfer into sealed tubes. Additionally, Samplfy's platform incorporates applications for digital detection and analysis of parameters like urine output and substances. This solution serves the healthcare industry, including clinics, hospitals, and laboratories, by addressing challenges in conditions such as UTIs, STIs, and high-risk pregnancies, ultimately reducing false results and repeated tests.

Company Intelligence Q&A

Who founded Samplfy?

Samplfy was founded by Varda Aberbach, who also serves as the CEO.

When was Samplfy founded?

Samplfy was founded in July 2020.

What is Samplfy's primary focus?

Samplfy focuses on developing a urine and data collection system specifically designed for women to ensure reliable test results, particularly for conditions like UTIs, STIs, and during pregnancy.

Does Samplfy hold any patents?

Yes, Samplfy holds a patent for its solution, which includes urine collectors for women and applications for digital detection and analysis of information.

What problem does Samplfy aim to solve?

Samplfy aims to solve the challenges associated with traditional urine collection methods for women, which often lead to improper samples, false or missing results, repeated tests, and incorrect treatments. Its device is designed to provide convenient and successful collection for high-quality samples.